Rabies

Rabies is a vaccine-preventable zoonotic viral disease caused by lyssaviruses, principally the rabies virus, which targets the central nervous system to produce progressive and fatal inflammation of the brain and spinal cord. The disease belongs to the order Mononegavirales, family Rhabdoviridae, genus Lyssavirus, and is characterized by its ability to infect all warm-blooded mammals, including humans. The virus is transmitted through direct contact with infected saliva, typically via bites or scratches, and establishes infection by migrating along peripheral nerves toward the central nervous system.

Clinical rabies presents in two recognized forms, though both progress inexorably toward death once symptoms manifest. The initial phase typically presents with nonspecific symptoms including fever, headache, and paresthesia at the exposure site, followed by progressive neurological involvement characterized by anxiety, insomnia, confusion, agitation, and in many cases hydrophobia or aerophobia. The incubation period ranges from one week to one year, with a typical duration of two to three months depending on viral load and distance from the peripheral entry point to the central nervous system. Once clinical signs appear, the disease is virtually 100% fatal, with death usually occurring within two to ten days despite intensive supportive care. No WHO-approved diagnostic tools exist for detecting infection before the onset of clinical disease, making early clinical diagnosis challenging without a reliable exposure history.

Rabies remains endemic on all continents except Antarctica, with an estimated 59,000 human deaths occurring annually across more than 150 countries. Approximately 95% of these deaths occur in Africa and Asia, where dog-mediated transmission persists as the dominant pathway. Children between 5 and 14 years of age represent frequent victims, and roughly half of all rabies fatalities occur in children under 15 years old. The disease burden falls disproportionately upon rural poor populations who lack access to affordable post-exposure prophylaxis, with the average cost of treatment estimated at US$ 108 per person—a prohibitive sum for those earning US$ 1–2 daily. In the Americas, where dog-mediated rabies has been largely controlled, hematophagous bats have emerged as the primary source of human rabies cases. The global economic burden is estimated at US$ 8.6 billion annually, encompassing direct medical costs, lost productivity, and unquantified psychological trauma.

Rabies is transmitted through direct contact with infected saliva, most commonly via bites but also through scratches,licks to broken skin, or contact with mucous membranes including the eyes, mouth, or open wounds. Dogs remain responsible for up to 99% of human rabies cases worldwide, though the virus naturally infects a broad range of mammals including cats, livestock, and wildlife species. Alternative transmission routes documented rarely include inhalation of aerosolized virus, consumption of raw meat or milk from infected animals, and organ transplantation. Human-to-human transmission through bites or saliva is theoretically possible but has never been confirmed. Bites from rodents are not known to transmit rabies, and transmission through unpasteurized milk remains unconfirmed by scientific evidence.

Children aged 5 to 14 years represent a particularly vulnerable population, both due to their higher likelihood of interaction with dogs and their smaller body size resulting in more severe exposures. Rural poor populations in Africa and Asia bear a disproportionate burden of disease, reflecting limited access to post-exposure prophylaxis, lower rates of dog vaccination, and occupational or residential exposure to free-roaming canids. Individuals with occupational exposure to potentially rabid animals, including veterinarians, animal handlers, and laboratory workers, face elevated risk and should receive pre-exposure prophylaxis. In regions where dog-mediated rabies has been controlled, populations with exposure to hematophagous bats, including those entering bat-inhabited caves or working in agricultural settings near bat colonies, constitute emerging risk groups.

Mass vaccination of dogs, including puppies, constitutes the most cost-effective strategy for preventing human rabies by interrupting transmission at its animal source; culling of free-roaming dogs has proven ineffective for rabies control. Post-exposure prophylaxis consisting of wound washing, rabies immunoglobulin administration, and a course of vaccinations can prevent disease onset if administered promptly after exposure. Over 29 million people receive rabies vaccination annually, though access remains inequitably distributed. Public education on dog behavior and bite prevention, appropriate wound care after animal contact, and responsible pet ownership represent essential complements to vaccination programs. Although effective human vaccines and immunoglobulins exist, their inaccessibility and unaffordability in endemic regions continue to impede elimination efforts.

Rabies surveillance presents particular challenges because no validated diagnostic methods exist for detecting infection prior to the onset of clinical symptoms, and clinical diagnosis remains difficult without a reliable history of exposure to a rabid animal or characteristic symptoms such as hydrophobia. The fluorescent antibody test remains the WHO reference standard for postmortem confirmation, detecting viral antigen in brain tissue, skin, or saliva. Accurate risk assessment following potential exposures is therefore essential for determining appropriate post-exposure prophylaxis administration. Underreporting is substantial, and documented case numbers frequently underestimate true disease burden, complicating epidemiologic assessment and resource allocation. Surveillance systems should incorporate both human and animal data to capture the full scope of rabies circulation within a given region.

1. 1 WHO Health Topics. Rabies.
2. 2 WHO Fact Sheet. Rabies.
3. 3 WHO Q&A. News.
4. 4 Wikidata. rabies.
5. 5 Wikipedia. Rabies - Wikipedia.

ICD-10

A82

ICD-11

1C82

Total cases

12K

Total deaths

11K

Peak month

2010-09

Coverage

4 reporting countries · 2000-01-01 → 2026-05-09